[pdf] patents office journal - Irish Patents Office
[pdf] patents office journal - Irish Patents Office
[pdf] patents office journal - Irish Patents Office
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
811<br />
(05/04/2006) <strong>Patents</strong> <strong>Office</strong> Journal (No. 2043)<br />
Request for Grant of Supplementary Protection Certificate<br />
The name and address of the requestor follow the number allocated to the request. The date in brackets<br />
following the name and address is the date of receipt of the request. The Patent number is that under which<br />
the product in respect of which a certificate is sought is, allegedly, protected. Market Authorisation<br />
references in respect of the product concerned are also shown.<br />
2006009 LES LABORATOIRES SERVIER, 22 rue Garnier, 92200 Neuillysur-Seine,<br />
France<br />
(1 March 2006)<br />
Patent No: 0534859; Benzocyclobutyl- or indanyl-alkyl-amino-alkyl<br />
substituted 3-benzazepin-2-ones useful in the treatment of<br />
cardiovascular diseases<br />
Product: Procoralan - Ivabradine<br />
Market Authorisation: Ireland EU/1/05/316/001-014, 25/10/2005<br />
Supplementary Protection Certificates Granted<br />
The name and address of the grantee follows the number allocated to the application for grant of a certificate;<br />
this number applies also to the granted certificate. The date in brackets following the name and address is the<br />
date of grant of the certificate. The number of the basic Patent and the title of the invention are followed by<br />
the name of the product for which the certificate is granted. Market authorisation references in respect of the<br />
product concerned are also shown, followed by the date of expiry of the certificate.<br />
2002032 E.I. du Pont de Nemours and Company, Wilmington, Delaware 19898, United<br />
States of America<br />
10/03/2006<br />
Patent No: 66407; Fungicidal oxazolidinones<br />
Product: A formulation comprising a mixture of famoxadone and cymoxanil<br />
Market Authorisation: Ireland AP01398, 14/05/2002<br />
Switzerland 5665, 11/12/1997<br />
Certificate Expires on: 10/12/2012<br />
2005002 ELI LILLY AND COMPANY, Lilly Corporate Center, Indianapolis, Indiana<br />
46285, United States of America<br />
08/03/2006<br />
Patent No: 60805; 3-Aryloxy-3-substituted propanamines<br />
Product: duloxetine and pharmaceutically acceptable acid addition salts thereof,<br />
and in particular, duloxetine hydrochloride<br />
Market Authorisation: Ireland EU/1/04/280/001-006, 11/08/2004<br />
Certificate Expires on: 17/12/2012<br />
2005003 MERCK FROSST CANADA & CO., Purdy`s Wharf Tower One, 1959 Upper<br />
Water Street, P.O. Box 997, Halifax, Nova Scotia B3J 2X2, Canada<br />
08/03/2006<br />
Patent No: 0863891; (Methylsulfonyl)phenyl-2-(5H)-furanones as cox-2